Neurodegenerative disease and cancer: two sides of a coin?
The mechanisms underlying disruption of physiologic cell-death programs are slowly being revealed. Information gleaned from genetic profiles soon may allow physicians to delay onset of many silent, age-related diseases. While development of actual cures could prove elusive, simply postponing clinical onset would have an impressive effect on the goal of healthy aging.
Bredesen
D E
DE
Buck Institute for Age Research, Novato, Calif., USA.
D000375:Aging / Q000502:physiology*; D017209:Apoptosis / Q000235:genetics*; D006801:Humans; D009369:Neoplasms / Q000209:etiology* / Q000235:genetics; D019636:Neurodegenerative Diseases / Q000209:etiology*; D011944:Receptors, Androgen / Q000378:metabolism; D015398:Signal Transduction
D011944:Receptors, Androgen